Drug Profile
Research programme: tuberculosis vaccine - Chongqing Zhifei Biological Products
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chongqing Zhifei Biological Products
- Class Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis(Prevention) in China
- 02 Apr 2013 Preclinical trials in Tuberculosis in China (unspecified route)